An article about the partnership between Elix, Inc. and PRISM BioLab Co., Ltd. was published on Nikkei Biotech ONLINE on April 14, 2025.

The article highlights PRISM BioLab’s collaboration with Elix to strengthen its drug discovery capabilities focused on PepMetics by leveraging Elix’s AI drug discovery platform.

▼The article can be accessed at the following link (Japanese only; Subscription required):
PRISM BioLab strengthens drug discovery technology specialized in PepMetics through business alliance with AI Drug Discovery Elix